| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0002 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.002 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.31 | 0.005 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.005 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.006 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |